CALC
CalciMedica, Inc.Company Information
- Company Name
- CalciMedica, Inc.
- CIK
- CIK0001534133
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CALC: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CALC
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-25
- Last sale
- 2025-07-25
- Shares purchased (TTM)
- 320,554
- Shares sold (TTM)
- 1,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 9,704,150
- Shares outstanding
- 17,100,457
- Ownership
- 56.75%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -34.04%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 19 | 8 | 12 | 5 | 6 | 13 | 8 | 9 | 5 | 7 | 6 | 12 | ||||||
| Short Term Investments | 0 | 0 | 1 | 9 | 12 | 12 | 11 | 5 | 14 | 19 | 6 | 3 | ||||||
| Restricted Cash | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | ||||||
| Assets Held For Sale Not Part Of Disposal Group | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Assets Current | 19 | 9 | 14 | 15 | 19 | 25 | 20 | 16 | 20 | 27 | 12 | 15 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Assets | 20 | 9 | 14 | 15 | 19 | 25 | 20 | 16 | 21 | 27 | 12 | 16 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | ||||||
| Other Accrued Liabilities Current | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | ||||||
| Liabilities Current | 3 | 5 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
Liabilities Other Than Long Term Debt Noncurrent | ||||||||||||||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities | 14 | 10 | 20 | 15 | 13 | 14 | 5 | 7 | 7 | 10 | 4 | 4 | ||||||
Stockholders Equity | ||||||||||||||||||
| Convertible Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Convertible Preferred Stock | ||||||||||||||||||
| Additional Paid In Capital Common Stock | 198 | 183 | 183 | 178 | 177 | 176 | 174 | 165 | 164 | 163 | 154 | 154 | ||||||
| Retained Earnings Accumulated Deficit | -192 | -184 | -189 | -179 | -171 | -165 | -160 | -156 | -150 | -146 | -146 | -142 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | - | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | - | ||||||
| Stockholders Equity | 6 | -1 | -7 | -0 | 6 | 11 | 14 | 9 | 14 | 17 | 8 | 12 | ||||||
| Liabilities And Stockholders Equity | 20 | 9 | 14 | 15 | 19 | 25 | 20 | 16 | 21 | 27 | 12 | 16 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Series A Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Series B Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Common Stock Shares Issued | 31 | 16 | 15 | 14 | 14 | 14 | 13 | 11 | 11 | 11 | 6 | 6 | ||||||
| Series C1 Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Series C2 Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Shares Outstanding | 31 | 16 | 15 | 14 | 14 | 14 | 13 | 11 | 11 | 11 | 6 | 6 | ||||||
| Series D Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCalciMedica, Inc. (CALC) — SEC Financial Statements & Analysis
CalciMedica, Inc. (CALC) is a pharmaceutical preparations company, incorporated in DE. CalciMedica, Inc. trades on Nasdaq as: CALC. CalciMedica, Inc. (CALC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, CalciMedica, Inc. carries a market cap of $88.07M, a P/E ratio of -4.15x, a P/B ratio of 15.97x, a P/S ratio of 195.27x, an enterprise value of $69.45M, and an EV/EBITDA multiple of -3.55x. On profitability, it posts an operating margin of -4351.66%, a net margin of -4709.53%, a Return on Equity (ROE) of -365.70%, a Return on Assets (ROA) of -110.10%, and a Return on Invested Capital (ROIC) of -556.40%. Per share, it reports EPS of $-1.24, diluted EPS of $-1.24, free cash flow per share of $-1.12, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -47.19% year-over-year, net income growth of 1.75% year-over-year, and EPS growth of -10.77% year-over-year. On the balance sheet, it maintains a current ratio of 5.58x, a quick ratio of 5.41x, working capital of $15.97M, a debt-to-equity ratio of 2.54x, a debt ratio of 0.72, an interest coverage ratio of -15.16x, free cash flow of $-19.12M (TTM), and net debt of $-18.62M. Figures sourced from SEC EDGAR.
- Market Cap
- $88.07M
- P/E TTM
- -4.15x
- EPS TTM
- $-1.24
- P/B TTM
- 15.97x
- ROE TTM
- -365.70%
- ROA TTM
- -110.10%
- Debt To Equity
- 2.54x
- Free Cash Flow TTM
- $-19.12M
- Net Revenue TTM Growth 1Y
- -47.19%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CalciMedica, Inc. in?
CalciMedica, Inc. (CALC) operates in the Pharmaceutical Preparations industry.
What exchange does CALC trade on?
CalciMedica, Inc. (CALC) trades on the Nasdaq.
Where is CalciMedica, Inc. incorporated?
CalciMedica, Inc. is incorporated in DE.
When was CalciMedica, Inc. (CALC)'s most recent SEC filing?
CalciMedica, Inc. (CALC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is CALC's market cap?
CalciMedica, Inc. (CALC) has a market capitalization of $88.07M as of 2026-06-30.
What is CALC's EPS (earnings per share)?
CalciMedica, Inc. (CALC)'s trailing twelve month EPS is $-1.24 as of 2026-06-30.
What is CALC's ROE (return on equity)?
CalciMedica, Inc. (CALC)'s trailing twelve month Return on Equity (ROE) is -365.70% as of 2026-06-30.
What is CALC's ROA (return on assets)?
CalciMedica, Inc. (CALC)'s trailing twelve month Return on Assets (ROA) is -110.10% as of 2026-06-30.
What is CALC's ROIC (return on invested capital)?
CalciMedica, Inc. (CALC)'s trailing twelve month Return on Invested Capital (ROIC) is -556.40% as of 2025-06-30.
What is CALC's EV/EBITDA?
CalciMedica, Inc. (CALC)'s trailing twelve month EV/EBITDA is -3.55x as of 2026-06-30.